Fougera Pharmaceuticals, LLC FDA Inspection Record
Fougera Pharmaceuticals, LLC is an FDA-registered facility (FEI 2410271) located in Hicksville, NY, US. Registered operations: LABEL; MANUFACTURE; PACK. RegDataLab tracks 13 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Mar 26, 2026: Voluntary Action Indicated (VAI)
- Inspections on record
- 13 (13 VAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Form 483 and inspection documents
- 1 in FDA's reading room
- Recalls as the recalling firm
- 1, latest Jun 7, 2012
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Mar 26, 2026 | Voluntary Action Indicated (VAI) | Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a)) |
| Nov 17, 2023 | Voluntary Action Indicated (VAI) | Investigations of discrepancies, failures (21 CFR 211.192) |
| Aug 10, 2022 | Voluntary Action Indicated (VAI) | Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a)) Absence of Written Procedures (21 CFR 211.100(a)) |
| Aug 8, 2019 | Voluntary Action Indicated (VAI) | Written procedures not established/followed (21 CFR 211.67(b)) |
| May 29, 2018 | Voluntary Action Indicated (VAI) | Procedures for non-sterile drug products (21 CFR 211.113(a)) |
| Nov 10, 2016 | Voluntary Action Indicated (VAI) | Calibration/Inspection/Checking not done (21 CFR 211.68(a)) Failing drug products not rejected (21 CFR 211.165(f)) |
| Dec 23, 2014 | Voluntary Action Indicated (VAI) | No citations listed |
| Dec 20, 2013 | Voluntary Action Indicated (VAI) | Labeling and packaging improperly approved/released (21 CFR 211.122(b)) |
| Nov 16, 2012 | Voluntary Action Indicated (VAI) | Packaging line inspection documentation (21 CFR 211.130(e)) |
| Feb 1, 2012 | Voluntary Action Indicated (VAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Jun 7, 2012 | Class III | D-1426-2012 | Erythromycin Topical Solution USP, 2%, 60 mL bottle with applicator, Rx only. E. FOUGERA &… Chemical Contamination: This product is being recalled because trace amounts of a plasticizer (Di-Octyl Phthalate) may be present in the… |
Form 483s and inspection documents
FDA record score
13 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
13 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Mar 26, 2026 | 6 x 1 | 6 |
| Inspection classified VAI | Nov 17, 2023 | 6 x 0.6 | 3.6 |
| Inspection classified VAI | Aug 10, 2022 | 6 x 0.6 | 3.6 |
| Inspection classified VAI | Aug 8, 2019 | Only the 3 most recent VAI inspections add points | 0 |
| Inspection classified VAI | May 29, 2018 | Only the 3 most recent VAI inspections add points | 0 |
| Inspection classified VAI | Nov 10, 2016 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Dec 23, 2014 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Dec 20, 2013 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Nov 16, 2012 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Feb 1, 2012 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Feb 9, 2011 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jan 12, 2010 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Feb 6, 2009 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Inspection citations | Nov 17, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 17, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 17, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 17, 2026 | Newest record Nov 16, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Fougera Pharmaceuticals, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Fougera Pharmaceuticals, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Fougera Pharmaceuticals, LLC.
- Location
- Hicksville, NY (US)
- Registration Expires
- Dec 31, 2027
- Operations
- LABEL; MANUFACTURE; PACK
- Source
- decrs